Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab for Relapse of Primary Malignancy After Allogeneic Hematopoietic Stem Cell Transplant: A Feasibility Study
Phase of Trial: Phase I
Latest Information Update: 22 Dec 2018
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 22 Dec 2018 Status changed from not yet recruiting to recruiting.
- 05 Dec 2017 Planned initiation date changed from 1 Nov 2017 to 1 Jan 2018.
- 23 Oct 2017 Planned initiation date changed from 1 Oct 2017 to 1 Nov 2017.